Back

Volume 18 , Issue 4
July/August 1998
Pages 389-401

Clinical Application of a New Bioresorbable Guided Tissue Regeneration Device: Case Reports

Parashis/Andronikaki-Faldami/Tsiklakis/van der Stelt

PMID: 12693425
DOI: 10.11607/prd.00.0276

Bioresorbable barriers have been recently introduced in clinical practice for guided tissue regeneration therapy. One of these is the Guidor matrix barrier, which is made of amorphous polylactic acid softened with a citric acid ester to increase malleability and facilitate clinical handling. The advantages of the bioresorbable barrier include: the elimination of second surgery; better handling and adaptation around the totoh and over the bone; and integration of the connective tissue of the flap with the barrier, preventing epithelial migration, gingival recession, and pocket formation. In the case of matrix exposure the material disappears within 6 to 8 weeks. The purpose of this report is to present the clinical application of the Guidor matrix barrier in the treatment of two- or three-wall intrabony defects that were followed up for more than 1 year. The evaluation included soft tissue changes using clinical parameters and ahr d tissue changes using nonstandardized digital subtraction radiography. In the authors’ opinion, the incorporation of a bioresorbable barrier in guided tissue regeneration therapy represents a significant improvement in the treatment of intrabony defects.

Full Text PDF File | Order Article

 

 

Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.